MBD

Gwabbit Founder, Todd Miller, Acquires Majority Interest in TRĒ AI, and is Appointed CEO

Retrieved on: 
Tuesday, April 2, 2024
Intelligence, Business, MBD, SAN, CRM, Contextual advertising, Conference, Marketing, Miller, Sales

SAN ANTONIO, April 2, 2024 /PRNewswire-PRWeb/ -- TRĒ AI, maker of the cutting edge TRĒ CRM for professional services announced today that Todd Miller has acquired majority interest in the company. Miller, the founder and former CEO of gwabbit, Inc, has also been named CEO of TRĒ AI.

Key Points: 
  • TRĒ AI, maker of the cutting edge TRĒ CRM for professional services announced today that Todd Miller has acquired majority interest in the company.
  • Miller, the founder and former CEO of gwabbit, Inc, has also been named CEO of TRĒ AI.
  • SAN ANTONIO, April 2, 2024 /PRNewswire-PRWeb/ -- TRĒ AI, maker of the cutting edge TRĒ CRM for professional services announced today that Todd Miller has acquired majority interest in the company.
  • Miller, the founder and former CEO of gwabbit, Inc, has also been named CEO of TRĒ AI.

Sigmetrix To Be Sponsors at the PTC/User Group Global Summit 2024

Retrieved on: 
Thursday, January 18, 2024
Creo, Architecture, ISO, ASME, CATIA, PTC, PTC Creo, Customer success, Knowledge, Partnership, Booth, NX, Digital thread, MBD, Language, Communication, Software, MBE, Model-based definition, Human, Workforce, Automation, CAD, EST, Risk management

MCKINNEY, Texas, Jan. 18, 2024 /PRNewswire-PRWeb/ -- Sigmetrix, global experts in mechanical variation management announced that they will be attending the PTC/User Global Summit 2024 being held from January 22-25 at the DoubleTree Hilton Orlando in Orlando, Florida at Booth #1020.

Key Points: 
  • MCKINNEY, Texas, Jan. 18, 2024 /PRNewswire-PRWeb/ -- Sigmetrix, global experts in mechanical variation management announced that they will be attending the PTC/User Global Summit 2024 being held from January 22-25 at the DoubleTree Hilton Orlando in Orlando, Florida at Booth #1020.
  • Major initiatives that are helping companies with this automation and quality/cost management are Model-Based Definition (MBD), Industry 4.0, and Digital Thread .
  • It is important that all requirements be tied directly to this comprehensive set of models to ensure traceability and usability.
  • On January 25, 2024, at 11:05AM EST, Raphael Nascimento will present, "Managing Mechanical Variation as part of the Digital Thread."

Atossa Therapeutics Announces Full Enrollment of Phase 2 Karisma-Endoxifen Clinical Trial

Retrieved on: 
Monday, November 20, 2023
MBD, Mammography, Risk, Woman, Breast cancer, Government, Principal, Ductal carcinoma, Breast, Therapy, Karolinska Institute, Cancer, Biostatistics, Pharmaceutical industry

MBD change is used as a proxy for therapy response.

Key Points: 
  • MBD change is used as a proxy for therapy response.
  • “Many of the risk factors for breast cancer, including breast density, are known, which means treating at-risk patient populations before the disease develops could significantly lower incidence rates,” said Dr.
  • “While significant progress has been made in breast cancer treatment, the same cannot be said about breast cancer prevention, particularly in high-risk women.
  • Both diagnoses are strong, independent predictors of breast cancer risk that we feel are modifiable with (Z)-endoxifen.”

TOYO Corporation Acquires Leading European Dynamometer Manufacturer Rototest

Retrieved on: 
Thursday, November 30, 2023
Automotive Manufacturing, Automotive, Technology, Manufacturing, Robotics, Other Automotive, General Automotive, Vehicle Technology, Machinery, Hardware, Machine Tools, Metalworking & Metallurgy, VIL, Multimedia, USD, Software, Partnership, Torque, DMTS, ADAS, EV, MBD, HIL, Radar

TOYO Corporation (TOYO), a leading provider of advanced measurement solutions and Rototest® International AB (Rototest), a global innovator in the development of hub-coupled powertrain dynamometers, today announced that TOYO has acquired Rototest on November 30, 2023, Japan time.

Key Points: 
  • TOYO Corporation (TOYO), a leading provider of advanced measurement solutions and Rototest® International AB (Rototest), a global innovator in the development of hub-coupled powertrain dynamometers, today announced that TOYO has acquired Rototest on November 30, 2023, Japan time.
  • Henceforth, Rototest, headquartered in Rönninge, Sweden, will operate as a subsidiary of TOYO.
  • Christian Engström, Rototest's CEO, expressed, "TOYO acquiring Rototest marks a significant milestone for the company.
  • With TOYO, Rototest is poised to enhance its ability to provide innovative automotive test solutions to an even broader array of the world's leading manufacturers."

The Potency of Partnership bridges further recognition for a 3x Inc 5000 Founder

Retrieved on: 
Tuesday, October 24, 2023
Exult Inc., Health, Heart, Life, Organization, Entrepreneurship, Creativity, Multimedia, Advertising, Trust, Collaboration, Virtue, Marketing, Partnership, Record, MDB, MBD

HUNTSVILLE, Ala., Oct. 24, 2023 /PRNewswire-PRWeb/ -- The power of partner weights in its alignment to legacy impact. The African proverb for going farther together crosses main domains both in life and business. Sustainment of fast growth is often a testament to the strength of partnerships and those behind the scenes aiding in it. Paul L Gunn Jr is a 3x Inc 5000 founder with 2 different companies. His most recent with Back-to-Back years making the list during the pandemic. "Being part of both the Inc 5000 and now receiving Inc's Power Partner Award, is deeply meaningful to our team," says, Mr. Gunn.

Key Points: 
  • Paul L Gunn Jr is a 3x Inc 5000 founder with 2 different companies.
  • "Being part of both the Inc 5000 and now receiving Inc's Power Partner Award, is deeply meaningful to our team," says, Mr. Gunn.
  • "Being part of both the Inc 5000 and now receiving Inc's Power Partner Award, is deeply meaningful to our team," says, Mr. Gunn.
  • Gaining this recognition and knowing the global applications to gain this recognition further weighted this award.

Diagmetrics Receives NIH RADx® Award to Advance its Mask Based Diagnostic Platform

Retrieved on: 
Wednesday, August 9, 2023
Condensate, Exhaled breath condensate, Electronics, Disability, Human services, Acceleration, COVID-19, United States Department of Health and Human Services, National Institute of Biomedical Imaging and Bioengineering, MBD, Diagnosis, Medical imaging, Federal, Biomarker, Tech, National Institutes of Health, Bangladesh Technical Education Board, Pandemic, EBC, OTC, Biological engineering, Controversies regarding COVID-19 contracts in the United Kingdom, NIH, Pharmaceutical industry

MADISON, Conn., Aug. 9, 2023 /PRNewswire-PRWeb/ -- DiagMetrics Inc. announced today that it has been awarded Phase 1 funding from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program in support of its Mask-Based Diagnostic (MBD™) for rapid detection of COVID-19 for use by individuals with disabilities. The initial award of $938,784.25 has the potential for Phase 2 funding pending successful completion of Phase 1. The RADx Tech award is funded by National Institute of Biomedical Imaging and Bioengineering (NIBIB) and will help DiagMetrics continue the development and validation of its novel Mask Based Diagnostic platform as it progresses to product commercialization.

Key Points: 
  • The initial award of $938,784.25 has the potential for Phase 2 funding pending successful completion of Phase 1.
  • The RADx Tech award is funded by National Institute of Biomedical Imaging and Bioengineering (NIBIB) and will help DiagMetrics continue the development and validation of its novel Mask Based Diagnostic platform as it progresses to product commercialization.
  • The DiagMetrics' MBD provides a simple way for users with disabilities to perform a COVID-19 test by themselves.
  • "The user simply puts on a mask, presses a button to activate the test, and breathes normally for a few minutes.

Mobidic (MBD) Is Now Available for Trading on LBank Exchange

Retrieved on: 
Friday, July 28, 2023
Blockchain, Growth, MBD, Ecosystem, NFT, Titanium SDK, Documentation, DAO, Dame Alice Owen's School, Cryptocurrency, MOBIDIC

Road Town, British Virgin Islands--(Newsfile Corp. - July 28, 2023) -  LBank Exchange, a global digital asset trading platform, listed Mobidic (MBD) on July 27, 2023.

Key Points: 
  • Road Town, British Virgin Islands--(Newsfile Corp. - July 28, 2023) -  LBank Exchange, a global digital asset trading platform, listed Mobidic (MBD) on July 27, 2023.
  • For all users of LBank Exchange, the MBD/USDT trading pair is now officially available for trading.
  • Mobidic (MBD) is a blockchain-based project to implement a decentralized autonomous organization (DAO).
  • By leveraging blockchain frameworks, Mobidic ensures reliability and transparency while promoting the growth of the DAO ecosystem through various features and protocols.

Atossa Therapeutics Provides Enrollment Update for Ongoing Phase 2 Karisma-Endoxifen Clinical Trial

Retrieved on: 
Monday, July 10, 2023
Breast, MBD, Cancer, Woman, Therapy, Mammography, Patient, Risk, Breast cancer, Atossa, Birth control, Medical imaging

SEATTLE, July 10, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer, today announced that 170 patients have been enrolled in the Company’s ongoing Phase 2 Karisma-Endoxifen clinical trial.

Key Points: 
  • SEATTLE, July 10, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer, today announced that 170 patients have been enrolled in the Company’s ongoing Phase 2 Karisma-Endoxifen clinical trial.
  • Atossa expects the study to fully enroll in the fourth quarter of 2023.
  • The Karisma-Endoxifen trial is a randomized, double-blind, placebo-controlled efficacy study of oral (Z)-endoxifen in premenopausal women with measurable breast density.
  • Participants receive daily doses of (Z)-endoxifen for six months, over the course of which mammograms are conducted to measure reduction in mammographic breast density (MBD).

Sigmetrix To Sponsor Siemens Realize LIVE Europe 2023 in Munich, Germany

Retrieved on: 
Thursday, June 29, 2023
Model-based enterprise, Workflow, MBD, Booth, GD, Implementation, Realize, Digital thread, MBE, Knowledge, Paradox Interactive, Model-based definition, Conference, Software, Tourism, Risk management

MICKINNEY, Texas, June 29, 2023 /PRNewswire-PRWeb/ -- Sigmetrix, global experts in mechanical variation management, announced that they will be sponsors at Siemens Realize LIVE Europe being held July 10-12 at the INFINITY Hotel & Conference Resort Munich.

Key Points: 
  • MICKINNEY, Texas, June 29, 2023 /PRNewswire-PRWeb/ -- Sigmetrix, global experts in mechanical variation management, announced that they will be sponsors at Siemens Realize LIVE Europe being held July 10-12 at the INFINITY Hotel & Conference Resort Munich.
  • At Realize LIVE Europe 2023, there will be a strong emphasis on exploring what transformation can look like using Siemens software.
  • Attendees will be able to receive technical and product training from none other than the vast global community of Siemens users.
  • The Sigmetrix team is excited to be exhibiting in the Solution Center to showcase their products and answer any questions attendees may have at Booth 13.

Sigmetrix To Sponsor Siemens RealizeLIVE Americas 2023 in Las Vegas, NV

Retrieved on: 
Wednesday, June 7, 2023
Model-based enterprise, Mandalay Bay Convention Center, Customer success, Workflow, Miss America 2023, MBD, Booth, GD, Implementation, Digital thread, MBE, Knowledge, Model-based definition, Software, Risk management

MCKINNEY, Texas, June 7, 2023 /PRNewswire-PRWeb/ --Sigmetrix, global experts in Mechanical Variation Management, announced that they will be sponsors at Siemens RealizeLIVE Americas being held June 12-15 at the Mandalay Bay Convention Center.

Key Points: 
  • MCKINNEY, Texas, June 7, 2023 /PRNewswire-PRWeb/ --Sigmetrix, global experts in Mechanical Variation Management, announced that they will be sponsors at Siemens RealizeLIVE Americas being held June 12-15 at the Mandalay Bay Convention Center.
  • At RealizeLIVE Americas 2023, there will be a strong emphasis on exploring what transformation can look like using Siemens software.
  • Attendees will be able to receive technical and product training from none other than the vast global community of Siemens users.
  • The Sigmetrix team is excited to be exhibiting in the Solution Center to showcase their products and answer any questions attendees may have at Booth 505.